Development of nanoparticle drug-delivery systems for the inner ear

被引:18
|
作者
An, Xiaogang [1 ]
Zha, Dingjun [1 ]
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Otolaryngol Head & Neck Surg, 127 Changle Western Rd, Xian 710032, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
blood-labyrinth barrier; hearing loss; inner ear; nanoparticle drug-delivery systems; nanoparticles; ROUND WINDOW MEMBRANE; IRON-OXIDE NANOPARTICLES; MODIFIED SILICA-NANOPARTICLES; OUTER HAIR-CELLS; HEARING-LOSS; PLGA NANOPARTICLES; STRIA VASCULARIS; GENE-THERAPY; MIDDLE-EAR; LIPOSOMAL NANOPARTICLES;
D O I
10.2217/nnm-2020-0198
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Hearing loss has become the most common sensory nerve disorder worldwide, with no effective treatment strategy. Low-permeability and limited blood supply to the blood-labyrinth barrier limit the effective delivery and efficacy of therapeutic drugs in the inner ear. Nanoparticle (NP)-based drugs have shown benefits of stable controlled release and functional surface modification, and NP-based delivery systems have become a research hotspot. In this review, we discuss the development of new targeted drug-delivery systems based on the biocompatibility and safety of different NPs in the cochlea, as well as the advantages and disadvantages of their prescription methods and approaches. We believe that targeted NP-based drug-delivery systems will be effective treatments for hearing loss.
引用
收藏
页码:1981 / 1993
页数:13
相关论文
共 50 条
  • [1] Nanoparticle drug delivery systems for inner ear therapy: An overview
    Valente, Filippo
    Astolfi, Laura
    Simoni, Edi
    Danti, Serena
    Franceschini, Valeria
    Chicca, Milvia
    Martini, Alessandro
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2017, 39 : 28 - 35
  • [2] Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle
    Colby, Aaron H.
    Oberlies, Nicholas H.
    Pearce, Cedric J.
    Herrera, Victoria L. M.
    Colson, Yolonda L.
    Grinstaff, Mark W.
    WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2017, 9 (03)
  • [3] Evaluation of nanoparticle drug-delivery systems used in preclinical studies
    Sreeharsha, Nagaraja
    Chitrapriya, Nataraj
    Jang, Yoon Jung
    Kenchappa, Vanaja
    THERAPEUTIC DELIVERY, 2021, 12 (04) : 325 - 336
  • [4] DRUG-DELIVERY SYSTEMS
    NIKANDER, K
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1994, 7 : S19 - S24
  • [5] Drug delivery to the inner ear
    Wise, Andrew K.
    Gillespie, Lisa N.
    JOURNAL OF NEURAL ENGINEERING, 2012, 9 (06)
  • [6] Development of drug-delivery systems to the posterior segments of the eye
    Yasukawa, Tsutomu
    Tabata, Yasuhiko
    Kimura, Hideya
    Kunou, Noriyuki
    Ogura, Yuichiro
    EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (02) : 197 - 211
  • [7] Intratympanic drug delivery systems to treat inner ear impairments
    Thu Nhan Nguyen
    Park, Jeong-Sook
    JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 53 (01) : 93 - 118
  • [8] Computational methodology for drug delivery to the inner ear using magnetic nanoparticle aggregates
    Talaska, Krzysztof
    Wojtkowiak, Dominik
    Wilczynski, Dominik
    Ferreira, Antoine
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2022, 221
  • [9] Intratympanic drug delivery systems to treat inner ear impairments
    Thu Nhan Nguyen
    Jeong-Sook Park
    Journal of Pharmaceutical Investigation, 2023, 53 : 93 - 118
  • [10] Pulsatile drug-delivery systems
    Bussemer, T
    Otto, I
    Bodmeier, R
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2001, 18 (05): : 433 - 458